Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.

Volaric, Ashley; Gentzler, Ryan; Hall, Richard; Mehaffey, James H; Stelow, Edward B; Bullock, Timothy N; Martin, Linda W; Mills, Anne M

Volaric, Ashley; Gentzler, Ryan; Hall, Richard; Mehaffey, James H; Stelow, Edward B; Bullock, Timothy N; Martin, Linda W; Mills, Anne M.

Afiliação

Volaric A; Departments of Pathology.
Gentzler R; Internal Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
Hall R; Internal Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
Mehaffey JH; Department of Surgery, Division of Thoracic Surgery.
Stelow EB; Departments of Pathology.
Bullock TN; Departments of Pathology.
Martin LW; Department of Surgery, Division of Thoracic Surgery.
Mills AM; Departments of Pathology.

Am J Surg Pathol ; 42(9): 1216-1223, 2018 09.

Article em En | MEDLINE | ID: mdl-29901571

Assuntos

Biomarcadores Tumorais/análise; Carcinoma Pulmonar de Células não Pequenas/enzimologia; Indolamina-Pirrol 2,3,-Dioxigenase/biossíntese; Neoplasias Pulmonares/enzimologia; Adulto; Idoso; Idoso de 80 Anos ou mais; Antígeno B7-H1/análise; Antígeno B7-H1/biossíntese; Resistencia a Medicamentos Antineoplásicos/fisiologia; Feminino; Humanos; Indolamina-Pirrol 2,3,-Dioxigenase/análise; Masculino; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google